Men, *Xiaoyu, Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Iii, C. F. R., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2025). UNDERSTANDING THE IMPACT OF CYP2D6-MEDIATED VENLAFAXINE PHARMACOKINETICS ON TREATMENT OUTCOMES IN LATE-LIFE DEPRESSION. International Journal of Neuropsychopharmacology, 28(Supplement_1), i329–i330. https://doi.org/10.1093/ijnp/pyae059.589

Kenowsky, S., Shao, Y., Heller, S., Golomb, J. B., Vedvyas, A., Dafflisio, G., Zhang, Q., Torossian, H., Sadowski, M. J., Wisniewski, T., Masurkar, A. V., & Reisberg, B. (2024). Nonpharmacologic Management of Behavioral and Psychological Symptoms of Dementia in Community‐Residing Persons with Moderately‐Severe Alzheimer’s Disease: One Year Results from a Randomized Controlled Trial. Alzheimer’s & Dementia, 20(S4). Portico. https://doi.org/10.1002/alz.090018

Laroy, M., Bouckaert, F., Ousdal, O. T., Dols, A., Rhebergen, D., van Exel, E., van Wingen, G., van Waarde, J., Verdijk, J., Kessler, U., Bartsch, H., Jorgensen, M. B., Paulson, O. B., Nordanskog, P., Prudic, J., Sienaert, P., Vandenbulcke, M., Oltedal, L., & Emsell, L. (2024). Characterization of gray matter volume changes from one week to 6 months after termination of electroconvulsive therapy in depressed patients. Brain Stimulation, 17(4), 876–886. https://doi.org/10.1016/j.brs.2024.07.015

Rizk, M. M., Bolton, L., Cathomas, F., He, H., Russo, S. J., Guttman-Yassky, E., Mann, J. J., & Murrough, J. (2024). Immune-Targeted Therapies for Depression. The Journal of Clinical Psychiatry, 85(3). https://doi.org/10.4088/jcp.23nr15243

Sajid, S., Galfalvy, H. C., Keilp, J. G., Burke, A. K., Mann, J. J., & Grunebaum, M. F. (2024). Acute Dissociation and Ketamine’s Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial. International Journal of Neuropsychopharmacology, 27(4). https://doi.org/10.1093/ijnp/pyae017

Men, X., Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Reynolds, C. F., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2024). CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression. Clinical Pharmacology & Therapeutics, 115(5), 1065–1074. Portico. https://doi.org/10.1002/cpt.3162

Jagtiani, A., Nagi, T., Gandhi, R., & Rizvi, A. (2024). Clozapine Withdrawal Catatonia: A Case Report. Cureus. https://doi.org/10.7759/cureus.52462

Baune, B. T., Minelli, A., Carpiniello, B., Contu, M., Domínguez Barragán, J., Donlo, C., Ferensztajn-Rochowiak, E., Glaser, R., Kelch, B., Kobelska, P., Kolasa, G., Kopeć, D., Martínez de Lagrán Cabredo, M., Martini, P., Mayer, M.-A., Menesello, V., Paribello, P., Perera Bel, J., Perusi, G., … Dierssen, M. (2024). An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1279688

Sajid, S., Lawrence, R. E., Galfalvy, H. C., Keilp, J. G., Moitra, V. K., Mann, J. J., & Grunebaum, M. F. (2024). Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale. Journal of Affective Disorders Reports, 15, 100690. https://doi.org/10.1016/j.jadr.2023.100690

Mariani, J. J., Dobbins, R. L., Heath, A., Gray, F., & Hassman, H. (2023). Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs. The American Journal on Addictions, 33(1), 8–14. Portico. https://doi.org/10.1111/ajad.13484

Suarez-Jimenez, B., Lazarov, A., Zhu, X., Pine, D. S., Bar-Haim, Y., & Neria, Y. (2022). Attention allocation to negatively-valenced stimuli in PTSD is associated with reward-related neural pathways. Psychological Medicine, 53(10), 4666–4674. https://doi.org/10.1017/s003329172200157x

Williams, A. R., Aronowitz, S., Gallagher, R., Behar, E., Gray, Z., & Bisaga, A. (2022). A Virtual-First Telehealth Treatment Model for Opioid Use Disorder. Journal of General Internal Medicine, 38(3), 814–816. https://doi.org/10.1007/s11606-022-07955-x

Bartlett, E. A., Yttredahl, A. A., Boldrini, M., Tyrer, A. E., Hill, K. R., Ananth, M. R., Milak, M. S., Oquendo, M. A., Mann, J. J., DeLorenzo, C., & Parsey, R. V. (2023). In vivo serotonin 1A receptor hippocampal binding potential in depression and reported childhood adversity. European Psychiatry, 66(1). https://doi.org/10.1192/j.eurpsy.2023.4

Bloomfield-Clagett, B., Ballard, E. D., Greenstein, D. K., Wilkinson, S. T., Grunebaum, M. F., Murrough, J. W., Mathew, S. J., Phillips, J. L., Fava, M., Sanacora, G., & Zarate, C. A. (2022). A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. International Journal of Neuropsychopharmacology, 25(10), 827–838. https://doi.org/10.1093/ijnp/pyac055

Mastrodonato, A., Pavlova, I., Kee, N. C., Pham, V. A., McGowan, J. C., Mann, J. J., & Denny, C. A. (2022). Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice. International Journal of Neuropsychopharmacology, 25(6), 512–523. https://doi.org/10.1093/ijnp/pyac020

Mastrodonato, A., Pavlova, I., Kee, N., McGowan, J. C., Mann, J. J., & Denny, C. A. (2022). Acute (R,S)-Ketamine Administration Induces Sex-Specific Behavioral Effects in Adolescent but Not Aged Mice. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.852010

Nestsiarovich, A., Reps, J. M., Matheny, M. E., DuVall, S. L., Lynch, K. E., Beaton, M., Jiang, X., Spotnitz, M., Pfohl, S. R., Shah, N. H., Torre, C. O., Reich, C. G., Lee, D. Y., Son, S. J., You, S. C., Park, R. W., Ryan, P. B., & Lambert, C. G. (2021). Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. Translational Psychiatry, 11(1). https://doi.org/10.1038/s41398-021-01760-6